Top 6 Quality Measures for Heart Disease Care in MIPS

The landscape of cardiovascular medicine in the United States is shifting. We no longer measure success only by procedure outcomes or patient volume. Instead, the focus has moved toward long-term stability and measurable health improvements. Cardiology practices now face a growing heart disease burden, driven by an aging population, which demands stronger clinical data management.

MIPS acts as the main framework guiding this shift. As CMS continues to refine value-based care, models like MIPS Value Pathways (MVPs) for Cardiology are beginning to shape how performance gets measured and reported. This blog explores how focusing on the top six quality measures can help your practice secure better financial standing while significantly moving the needle on heart disease care.

Understanding MIPS Value Pathways (MVPs) for Cardiology 

To succeed in value-based care, you need to understand how CMS evaluates performance. MIPS is not a singular test; it is a composite score derived from four distinct pillars:

• Quality: This replaces the old PQRS system and measures the effectiveness of the care provided.
• Promoting Interoperability: This focuses on how well your EHR communicates with other systems and patients.
• Improvement Activities: This tracks the specific actions you take to improve patient access and safety.
• Cost: This evaluates the total cost of care for the patients you treat.

For cardiologists, the Quality category often carries the most weight in scoring. It accounts for a large portion of the final score and is the area where clinicians have the most direct control. High performance in these measures does not just avoid a penalty but signals to the market that your practice is a leader in evidence-based medicine.

Why Quality Measures Matter in Heart Disease Care?

Standardized outcomes serve as a key benchmark in modern cardiology. When every provider in a practice follows the same quality benchmarks, care gaps become obvious. We can see exactly which patients are missing their therapy or which lifestyle interventions are falling short. This structured data improves preventive cardiology and ensures patients’ long-term outcomes are actively managed.

6 MIPS Quality Measures for Heart Disease Care

These quality measures not only drive current MIPS performance but also align closely with emerging frameworks like MIPS Value Pathways (MVPs) for Cardiology, making them even more critical for future reporting. 

Measure #1: Controlling High Blood Pressure

Hypertension is widely known as the “silent killer” because it often shows no symptoms until complications occur. It is the primary driver of strokes and heart attacks, yet it is often the most poorly managed chronic condition. Under MIPS, this measure tracks the percentage of patients (ages 18–85) who have a diagnosis of hypertension and whose last blood pressure reading was less than 140/90 mmHg.

The Impact of Control

Lowering blood pressure even by a few points can drastically reduce the risk of a major adverse cardiac event (MACE). For a cardiology practice, achieving high scores in this measure proves that the care team is managing the “basics” with precision.

Measure #2: Statin Therapy for Patients with Cardiovascular Disease

Statins remain one of the most effective tools for secondary prevention. This MIPS measure focuses on ensuring that patients with established clinical atherosclerotic cardiovascular disease (ASCVD). Therefore, they are prescribed high or moderate-intensity statin therapy.

Addressing Care Gaps

The gap in statin therapy often stems from two areas: patient hesitation due to misconceptions about muscle pain and a lack of follow-up on lab results. To improve performance, practices should implement a standard protocol for lipid management.

• Eligibility Criteria: Ensure your EHR correctly flags patients with a history of MI, CABG, or stroke, so they are automatically considered for this measure.
• Patient Education: Many patients fear statins because of misinformation. Providing high-quality, professional brochures or short digital videos during the waiting period can demystify the treatment.

Measure #3: Beta-Blocker Therapy After a Heart Attack

Following a myocardial infarction (MI), the heart is in a vulnerable state. Beta-blockers are essential because they reduce the heart’s workload and prevent dangerous arrhythmias. MIPS Value Pathways (MVPs) for Cardiology is the percentage of patients who were prescribed a beta-blocker upon discharge and through the following months of recovery.

Improving Post-MI Workflows

The challenge here is often the transition of care. When a patient moves from the hospital back to the outpatient clinic, medication lists can become muddled.

• Coordination: Establish a “Post-MI Bundle” in your clinic. Every patient returning from a hospital stay should have their beta-blocker status checked at the very first follow-up appointment.
• Reducing Mortality: Remind your clinical team that this isn’t just about a score but about the fact that beta-blockers are proven to reduce post-MI morbidity.

Measure #4: Cardiac Rehabilitation Referral

Research consistently shows that patients who attend cardiac rehabilitation have significantly lower rates of rehospitalization and death. Despite this, referral rates remain lower than they should be. This MIPS measure tracks how often clinicians refer eligible patients (those who have had a heart attack, heart failure, or heart surgery) to a rehab program.

Strategies for Success

• Automated Triggers: Your EHR should be programmed to flag every MI or heart failure patient for a rehab referral. If the referral isn’t made, the system should prompt the clinician for a reason.
• Facility Collaboration: Build relationships with local rehab centers. When the referral process is a direct referral transition between providers
•  rather than a piece of paper, patients are much more likely to show up for their first session.

Measure #5: Atrial Fibrillation (AFib) and Anticoagulation Therapy

AFib is a major risk factor for ischemic stroke. This measure evaluates the percentage of patients with AFib who are prescribed anticoagulant therapy, such as warfarin or direct oral anticoagulants (DOACs).

Closing the Care Gap

Many clinicians hesitate to prescribe anticoagulants for older patients due to fall risks. However, the risk of a devastating stroke usually outweighs the risk of a bleed.

• Risk Assessment: Use standardized tools like the CHA2DS2-VASc score to justify your clinical decisions.
• Patient Safety: If a patient is not a candidate for anticoagulation, ensure that the “medical reason for exclusion” is documented clearly in the EHR to protect your MIPS score.

Measure #6: Smoking Cessation Intervention

Tobacco use is perhaps the most avoidable risk factor in cardiology. This measure requires practices to screen every patient for tobacco use and, for those who use it, provide cessation counseling or medication.

Moving Beyond “Do You Smoke?”

A simple “yes” or “no” isn’t enough for high-quality care.

• Pharmacotherapy: Combining nicotine replacement therapy (NRT) with behavioral support is the gold standard.
• Referral Programs: Utilize state-funded quit lines or in-house counseling. Showing the patient that you are invested in their journey to quit builds immense trust and improves their long-term cardiac outlook.

Best Practices for High-Performance Cardiology Teams

Achieving excellence in these six measures requires more than just clinical skill; it requires operational discipline.

1. Leverage EHR Features

Your EHR should function as an active clinical system, not just a storage tool. Use it as a proactive assistant. Set up dashboards that show your performance on these six measures in real-time.If your statin therapy score drops, address it immediately rather than waiting for the delaying action until annual reporting.

2. Strengthen Care Coordination

Cardiology does not happen in a vacuum. Effective communication with primary care physicians (PCPs) is vital. When a PCP knows exactly why a cardiologist started a patient on a specific beta-blocker or anticoagulant, they are less likely to stop that medication during a routine wellness visit.

3. Improve Patient Engagement

A patient who understands their numbers is empowered. Use telehealth and mobile apps to keep the conversation going. For example, a quick message to a patient regarding their blood pressure trend can prevent a hypertensive crisis.

Common Challenges & How to Overcome Them

• Incomplete Documentation: Train your staff specifically on MIPS coding to ensure every reportable outcome is accurately documented
• Patient Non-Adherence: Use digital reminders and telehealth check-ins to keep patients on track with their meds.
• Limited Resources: Consider delegating MIPS tracking to a specific care coordinator to free up physician time.

Impact on MIPS Scores & Revenue

Focusing on these six measures does more than just help patients; it protects your bottom line. High quality scores lead to positive payment adjustments. Conversely, ignoring these metrics reduces reimbursement opportunities and puts your practice at a competitive disadvantage in the value-based care market.

Conclusion

Mastering these quality measures moves your practice from just “checking boxes” to truly proactive care. As CMS continues shifting toward MIPS Value Pathways (MVPs) for Cardiology, practices that already perform well on these measures will stay ahead of compliance and reimbursement changes. The metrics function as a protective system which prevents your most at-risk patients from being abandoned. 

QPPMIPS can eliminate your reporting responsibilities. This solution removes all technical difficulties which enables you to concentrate on patient care instead of worrying about compliance issues. In today’s market, your data defines your reputation. Nailing these outcomes now is the best way to protect both your patients’ health and your practice’s future.

FAQs

Q1: Which MIPS Value Pathways for Cardiology are most important for cardiologists? 

The six measures detailed here are blood pressure control, statin therapy, beta-blocker use, rehab referrals, AFib anticoagulation, and smoking cessation which represent the most critical pillars of heart disease management.

Q2: Are these measures mandatory? 

While you have a menu of measures to choose from in MIPS, these six are highly recommended because they align with the American College of Cardiology (ACC) guidelines and carry significant weight in scoring.

Q3: How often should we review our performance data? 

The best time for conducting evaluations occurs every month. This method enables you to track patterns while you correct documentation mistakes which will become permanent in your yearly report.

Q4: Can small practices compete with large health systems in MIPS? 

Yes. Smaller practices have better operational capabilities because they can move quickly to make decisions. A small practice can achieve better results than a large fragmented system when it has a dedicated team and an optimized electronic health record system.

Q5: Do these measures align with clinical guidelines? 

Absolutely. The current procedures are established to show the most recent research-based methods which the American College of Cardiology and the American Heart Association have established as valid.